| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.51 | 0.08 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.37 | 0.2 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.19 | 0.0006 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 0.1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |